1-3 of 3
Quihong Zhao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparison of Long-Term Outcomes Among Patients with Chronic Myeloid Leukemia Who Undergo Initial Tyrosine Kinase Inhibitor Dose Reduction Versus Tyrosine Kinase Inhibitor Switch

Melanie T Rebechi, Quihong Zhao, Michael Marcucci, Nidhi Sharma, Allyson Waller, Marvellous Olowookere, Alyssa Swank, Christian Hu, Alice Mims, Jennifer E. Vaughn
Journal: Blood
Blood (2024) 144 (Supplement 1): 1771.
https://doi.org/10.1182/blood-2024-203869
Published: 2024
Journal Articles

Understanding Valuation of Tyrosine Kinase Inhibitors Among Patients with Chronic Myeloid Leukemia Using a Novel Hypothetical Purchasing Task

Jennifer E. Vaughn, Quihong Zhao, Michael Marcucci, Nidhi Sharma, Alice Mims, Allyson Waller, Jeff Stein
Journal: Blood
Blood (2024) 144 (Supplement 1): 5049.
https://doi.org/10.1182/blood-2024-203641
Published: 2024
Journal Articles

A Phase 2 Study of Lenalidomide to Repair Immune Synapse Response and Humoral Immunity in Early-Stage, Asymptomatic Chronic Llmphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) with High-Risk Genomic Features

Jeffrey A. Jones, MD MPH, Amy J. Johnson, PhD, Farrukh T. Awan, Quihong Zhao, MAS, Natarajan Muthusamy, DVM, PhD, Kami J. Maddocks, MD, Leslie A. Andritsos, MD, Kerry A. Rogers, MD, Jennifer A. Woyach, MD, Gerard Lozanski, MD, Nyla A. Heerema, PhD, Cathy Brookfield, BSN, Amy S Ruppert, MAS, John C. Byrd, MD
Journal: Blood
Blood (2016) 128 (22): 4388.
https://doi.org/10.1182/blood.V128.22.4388.4388
Published: 2016